Is Testosterone Therapy Safe for Gender-Diverse Individuals?

Transmasculine and gender-diverse individuals using testosterone in the early years of hormone therapy do not face a higher risk of developing gynecological cancers, according to large-scale research by Amsterdam UMC published in eClinicalMedicine

Transmasculine and gender-diverse people registere as women at birth.

But do not feel male, non-binary or otherwise at home within the traditional image of being a woman. Many of them choose to use testosterone: a hormone therapy that induces physical changes that are more in line with their gender identity and/or expression.

No Detected Cases of Gynecological Cancer

Asra Vestering, researcher at Amsterdam UMC, explains: “We found no increased risk of these cancers compared to women from the general เล่นบาคาร่า UFABET เว็บตรง ค่าคอมสูง population. None of these cancers were diagnose in the entire participant group. This is valuable information for both healthcare providers and transmasculine and gender-diverse people who are considering starting hormone therapy.”

Impact of Changing Legal Landscape

In recent years, gender registration legislation in the Netherlands has relax, making surgical gender removal no longer a requirement to legally change gender. As a result, more and more transmasculine and gender-diverse people are choosing to start hormone therapy first, without undergoing sex removal surgery (immediately).